Aastrom Biosciences (ASTM) Improves Its Management Team

Aastrom Biosciences (ASTM) announced this morning (02014.04.01) the appointment of a Chief Scientific Officer and a Chief Medical Officer. The company's press release had the following sub-headline: Globally Recognized Industry Veterans Bring Extensive R&D and Product Development Experience in Regenerative Medicine and Multiple Therapeutic Areas. Hmm... Do two globally recognized sailors jump aboard a sinking ship?

ASTM closed yesterday (02014.03.31) at $4.39.